Targeting impulsivity in Parkinson's disease using atomoxetine
about
The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy peopleGambling disorder: an integrative review of animal and human studies.Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?Response inhibition in Parkinson's disease: a meta-analysis of dopaminergic medication and disease duration effectsDopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive DisordersParkinson's disease dementia: a neural networks perspective.Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease.Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease?Time on timing: Dissociating premature responding from interval sensitivity in Parkinson's disease.Cognitive Flexibility: A Default Network and Basal Ganglia Connectivity Perspective.Therapy-resistant symptoms in Parkinson's disease.Cognitive decline in Parkinson disease.Atomoxetine restores the response inhibition network in Parkinson's disease.Slowness in Movement Initiation is Associated with Proactive Inhibitory Network Dysfunction in Parkinson's Disease.Repeated Sprints in Fasted State Impair Reaction Time Performance.A neurological perspective on the enhancement debate: Lessons learned from Parkinson's disease.Fractionating impulsivity: neuropsychiatric implications.Cross-species studies of cognition relevant to drug discovery: a translational approach.Locus coeruleus.Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's diseaseApathy and impulsivity in frontotemporal lobar degeneration syndromes.The neurobiology of impulse control disorders in Parkinson's disease: from neurotransmitters to neural networks.Neurotransmitter deficits from frontotemporal lobar degeneration.Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible?Motivational Sensitivities Linked to Impulsive Motor Errors in Parkinson's Disease.Management of impulse control disorders in Parkinson's disease.Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases-An Overview of Imaging Studies.Demographic and Clinical Predictors of Trait Impulsivity in Parkinson's Disease Patients.Mild Cognitive Impairment in Parkinson's Disease-What Is It?Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity
P2860
Q26799352-7730FB37-44FF-4AFA-A0E0-E9E1485D7ECEQ30234518-9966DCFD-5959-436B-9D5F-1E546D2D9EE9Q31080551-0E4DD322-B160-4C15-A7A8-60BEFD92EE34Q33885120-8F7AD66D-1170-4984-A05A-0B3401155E4CQ35795738-63DB90DA-F777-459A-B349-B977A5A6B3D0Q36186763-93D3E6AA-14D1-4B25-B2E9-D44736967A5DQ36762203-2D2CF387-E9DC-4447-BE08-AA5BE5F5C5EAQ36870256-56FBF0BE-D4FE-488F-8632-621AE25B21D8Q36946063-2127773E-22A0-466A-A995-9AA717B68416Q37183142-619EC742-AA40-42A1-B3E3-0C0F97B901F1Q37428544-671C6F87-FE29-4064-A99F-7E8D87C0B7B4Q38593798-91A04034-E491-4C85-BC92-048B682BD669Q38751099-E9EA21E7-DC7E-4545-AC24-0B3BF677CCEBQ38848619-783C9207-6895-44F3-945F-912F2D1AD12CQ38883609-D3178078-9F0A-49E4-A028-49725BB50FCBQ38943384-9904814C-A711-471C-8515-8D6FEE38AD59Q38948788-907B0B4A-00AA-4DAD-B22B-05F5C3C4DC24Q39139768-BF42F44B-AEF5-40A9-9818-E10AD7648683Q39256002-3B469F4C-5F00-4B31-A188-38397A07F2B8Q39422119-F56A79E4-E574-440F-865D-38ED99A119A4Q42290120-30570369-E0FA-4B34-8503-B3108253CEB5Q47322264-D99AB11C-9EE2-4158-9732-2C1FC6412444Q47830362-E078DCFE-5CCA-41AB-BDA1-740E58FA411BQ47837913-D91820EF-EBFC-4392-979E-05A2675BB915Q48091456-17F53BAD-882F-461E-AF5A-4D6E8D54115EQ48144827-03DEE73A-34E1-4B83-8F5B-C9C724A4B5A1Q48177158-18E95CAE-B735-41C4-A062-02F2667B69B3Q55004525-371798FA-AF83-430B-B147-2298C3730FB4Q55313442-366B35E8-D973-48B8-B961-19F6D730F985Q55387790-D7D0247A-EBCB-4A03-987C-04EE484C58DDQ57490275-2249E9F9-0402-4EC5-AB99-AB1917811373
P2860
Targeting impulsivity in Parkinson's disease using atomoxetine
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting impulsivity in Parkinson's disease using atomoxetine
@ast
Targeting impulsivity in Parkinson's disease using atomoxetine
@en
type
label
Targeting impulsivity in Parkinson's disease using atomoxetine
@ast
Targeting impulsivity in Parkinson's disease using atomoxetine
@en
prefLabel
Targeting impulsivity in Parkinson's disease using atomoxetine
@ast
Targeting impulsivity in Parkinson's disease using atomoxetine
@en
P2093
P2860
P50
P356
P1433
P1476
Targeting impulsivity in Parkinson's disease using atomoxetine
@en
P2093
Angie A Kehagia
Charlotte R Housden
Ulrich Müller
P2860
P304
P356
10.1093/BRAIN/AWU117
P407
P577
2014-06-03T00:00:00Z